GE HealthCare has launched its next generation of Logiq ultrasound systems, featuring new AI-powered automation tools and enhanced liver assessment capabilities.
The Logiq E10 system.GE HealthCare
The updated portfolio -- which includes the Logiq E10 series, Logiq Fortis, and Logiq Totus -- incorporates new clinical tools such as ultrasound-guided fat fraction, designed to support more consistent assessment of liver fat burden for patients with metabolic dysfunction-associated fatty liver disease, GE HealthCare said.
The systems feature new AI-powered tools, such as Auto Abdominal Suite 2.0 with SmartEdit capabilities, which, when combined with Scan Assistant, have supported 65% faster measurements and 80% fewer system interactions for more consistent imaging and improved exam efficiency, the company said.
In addition, an expanded open digital platform enables integration of third-party applications in the systems alongside the company's Verisound Digital offerings and includes on-scanner ViewPoint reporting capability, currently available only in the U.S., GE HealthCare noted.
The company said it plans to showcase the new Logiq systems at the European Congress of Radiology 2026 in Vienna, being held March 4 to 7.
![Examples of ultrasound findings and techniques. (A) Images in a 39-year-old male patient with a mass in the left thigh. The mass is heterogeneous on the B-mode US image (compared with the patient in D) and showed increased microvascularity (superb microvascular imaging [SMI]) and shear-wave elastography (SWE) values. Undifferentiated pleomorphic sarcoma was diagnosed at biopsy (with pleomorphic rhabdomyosarcoma in surgical specimen). (B) Images in an 18-year-old male patient with a mass in the left leg. The mass is hypoechoic on the B-mode image, with no other findings suggestive of malignancy. The lesion is in contact with the cortex of the tibia, which is slightly irregular. CT revealed a doubtful anteromedial tibial erosion. The microvascular study demonstrated high vascularization, suggestive of malignancy. Periosteal Ewing sarcoma was diagnosed with both histologic and immunohistochemical confirmation. (C) Images in a 69-year-old female patient with a lump growing on the outside of the left leg. Multiple SWE examinations were performed (please note the high values obtained in the measurements, whereas the color map highlights the stiffness relative to adjacent tissues). SMI showed areas of increased vascularization to target for sampling. Undifferentiated spindle cell sarcoma was diagnosed at biopsy, with residual leiomyosarcoma in the surgical specimen after neoadjuvant therapy. (D) Images in a 56-year-old female patient with a mass in the right thigh. The mass is heterogeneous at both B-mode ultrasound (similar to patient A) and MRI (coronal T2-weighted spectral attenuated inversion recovery [SPAIR]; T1-weighted pre-contrast and postcontrast imaging), which even shows uptake after the administration of paramagnetic contrast material, which is traditionally suggestive of malignancy. Low values at SMI and elastography are suggestive of benignity. Spindle cell lipoma was diagnosed at biopsy, with atypical spindle cell lipomatous tumor in the surgical specimen.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/08/images-radiol250278fig2.APCFLSvX6p.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
